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Thymic skewing of the CD4/CD8 ratio maps with the T-cell
receptor a-chain locus
Bee-Cheng Sim*, Najla Aftahi*, Christina Reilly*, Bjarne Bogen†, 
Ronald H. Schwartz‡, Nicholas R.J. Gascoigne* and David Lo*
The thymic preference for CD4+ T cells over CD8+ T cells
is often attributed to a default pathway favouring CD4+
T cells [1] or to homeostatic mechanisms [2,3]. It is also
clear, however, that T-cell receptor (TCR) preferences
for major histocompatibility complex (MHC) class I
versus class II binding will strongly influence an
individual clone’s skewing to the CD4 or CD8 subset [4].
The variable region of each TCRa chain (Va) studied to
date is found to be overrepresented in either CD4+
[5–7] or CD8+ cells [7–9], suggesting that each Va
element can interact more favourably with either MHC
class I or class II molecules [10]. Indeed, TCRs appear
to have an intrinsic ability to interact with MHC
molecules [11,12], and single amino acid residues
present in germline-encoded complementarity
determining region 1 (CDR1) and CDR2 of the Va
element can be responsible for determining MHC
specificity [13]. Interestingly, the degree of CD4/CD8
skewing is variable among different mouse strains
[14,15] and in human populations [16]. Here, we have
shown that polymorphism in CD4/CD8 skewing
between B6 and BALB/c mice is determined by the
stem cell genotype and not by environmental effects,
and that it maps in or near the TCR a-chain complex,
Tcra. This was confirmed by comparing Tcrab with
Tcraa or Tcrac haplotypes in congenic mice. We
propose that the array of Va genes in various Tcra
haplotypes exerts influence over the proportion of CD4
and CD8 subsets generated and may account in part for
the observed thymic skewing. Thus, while it has been
suggested that the TCR genes have been selected by
evolution for MHC binding, our results further indicate
selection for class II MHC preference.
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Results and discussion
CD4/CD8 ratio is influenced by the genotype of the donor
stem cells
Polymorphism among various mouse strains in the ratio
between peripheral lymph node CD4+ and CD8+ T cells
has been well documented (see Supplementary material
published with this paper on the internet) [14,15]. In B6
versus BALB/c strains, this also correlates with differ-
ences in T-cell responses; thus, CD4/CD8 ratios may
reflect differences in the strength of interactions between
T-cell subsets. To test this issue, we generated mixed
bone marrow chimæras from two strains with distinct
CD4/CD8 ratios. Despite the mixing of cells in both the
thymus and periphery, the CD4/CD8 ratios of the two
types of T cells reflected their bone marrow origin (see
Supplementary material); thus, BALB.B cells (Thy-1.2+)
showed a high CD4/CD8 ratio compared to B6.PL cells
(Thy-1.1+), whether alone in the chimæra or in mixtures
with B6.PL cells. Control chimæras of B6 bone marrow
cells (Thy-1.2+) alone or in a mixture with B6.PL cells
showed no significant difference in the CD4/CD8 ratio.
These results indicated that the CD4/CD8 ratio was fixed
by a stem-cell-autonomous factor and was not influenced
by other bone-marrow-derived cells.
Thymic CD4/CD8 ratios of CB6F2 mice show a pattern of
inheritance correlating with Tcra
We found that thymic CD4/CD8 skewing is similarly
influenced by background genes, and that the strain dif-
ferences were even more pronounced than in peripheral
cells. For example, B6 thymi showed a consistently lower
CD4/CD8 ratio than BALB/c thymi (Figure 1a), suggest-
ing that the differences in skewing were in part a conse-
quence of thymic repertoire selection. To identify the
genes responsible for this influence over thymic selection,
we generated an F2 cross between B6 and BALB/c mice
(CB6F2). The CD4/CD8 ratio from thymus was derived
from fluorescence-activated cell sorting (FACS) analysis of
each individual F2 animal, and the genotype at loci cover-
ing most of the mouse genome was determined [17]. The
thymic CD4/CD8 ratio showed a striking co-dominant
pattern of inheritance strongly correlating with the geno-
type at a locus 18.5–19.5 cM from the centromere on chro-
mosome 14 (p = 0.0007; Figure 1b, Table 1 and
Supplementary material). Peripheral lymph node data (see
Supplementary material) showed similar results. Several
genes of interest map to this region, the most striking
being the TCR α-chain complex (Tcra, 19.7 cM). Consis-
tent with this, re-analysis of a survey of CD4/CD8 ratios
among common mouse strains [15] showed a strong corre-
lation between CD4/CD8 ratios and Tcra haplotype (see
Supplementary material).
A significant association was also found between
CD4/CD8 ratios and the H-2 locus (mouse MHC, span-
ning ~ 18.4–24.5 cM) on chromosome 17. A weaker
linkage on chromosome 16 (p = 0.0415) was found with
marker D16Mit84 at 32.3 cM, probably due to the Mtv6
locus (27.5 cM) encoding the viral superantigen-6
(vSAg6, Mls-3a), which in BALB/c mice causes deletion
of CD4+CD8– thymocytes bearing Vβ3 and Vβ5 [18]. In
both cases, the higher CD4/CD8 ratio was associated
with the b allele, the reverse of the difference observed
between B6 and BALB/c strains. Thus, although MHC
and Mtv6 may influence CD4/CD8 ratios, they do not
explain the major effect seen in this study. Interestingly,
we also found significant effects on CD4/CD8 ratios
among CD3– cells (see Supplementary material), which
may suggest that events early in thymocyte develop-
ment are also influencing commitment to the CD4 or
CD8 lineage.
Polymorphism in the Tcra region is sufficient to alter the
CD4/CD8 ratio
To control for background gene effects, two strains of
mice congenic at Tcra were tested (Figure 2a). First,
B10.D2-Tcraa/Bo mice congenic at the Tcra locus (B10.D2
mice with the Tcraa locus from BALB/c) [19] were com-
pared to B10.D2 (Tcrab) mice. Thymic CD4/CD8 ratios
confirmed that polymorphisms in the region around the
Tcra locus alone appear sufficient to alter the CD4/CD8
ratio (Figure 2b). These differences were not fully equiva-
lent to the differences between B6 and BALB/c, suggest-
ing that other genetic polymorphisms between B6 and
BALB/c also have some influence over the CD4/CD8
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Segregation of CD4/CD8 ratio with Tcra haplotype. (a) B6 and BALB/c
thymic CD4/CD8 ratio. The CD4+ and CD8+ single-positive thymocytes
are boxed. Numbers in bold at the top right of each dot plot reflect the
CD4/CD8 ratio. For B6, the geometric mean (± standard deviation, SD)
is 3.56 (± 1.07) and for BALB/c, 6.56 (± 1.07) (p = 0.0004 by student’s
t-test). (b) CD4/CD8 ratio segregates with Tcra haplotype. The scatter
plot represents the thymic CD4/CD8 ratio for individual CB6F2 mice
with BALB/c and B6 alleles, denoted as ‘a’ and ‘b’, respectively. 
Table 1
The CD4/CD8 ratio of CB6F2 mice is linked to the genotype on chromosome 14. 
Microsatellite marker Chromosome cM CB6F2 ‘a’ CB6F2 ‘a/b’ CB6F2 ‘b’ p value
D3Mit65 3 23.3 3.7 (± 1.4) 3.7 (± 1.6) 3.1 (± 1.6) 0.3945
D3Mit106 3 55.0 3.3 (± 1.8) 3.3 (± 1.5) 4.2 (± 1.6) 0.4938
D11Mit230 11 16.0 3.7 (± 1.5) 4.0 (± 1.4) 3.2 (± 1.7) 0.7508
D14Mit101 14 17.0 4.9 (± 1.4) 3.6 (± 1.3) 1.9 (± 1.5) 0.0010
D14Mit62 14 18.5 4.9 (± 1.4) 3.5 (± 1.3) 1.9 (± 1.5) 0.0007
D14Mit142 14 19.5 4.9 (± 1.4) 3.5 (± 1.3) 1.9 (± 1.5) 0.0007
D14Mit113 14 25.0 4.8 (± 1.4) 3.8 (± 1.3) 1.9 (± 1.5) 0.0021
D16Mit84 16 32.3 3.6 (± 1.4) 3.0 (± 1.6) 5.1 (± 1.3) 0.0415
MM23 17 19.1 2.4 (± 1.6) 4.0 (± 1.5) 4.0 (± 1.2) 0.0279
D17Mit178 17 24.5 2.3 (± 1.5) 4.2 (± 1.6) 4.0 (± 1.2) 0.0074
The complete table is presented in the Supplementary material. The thymic CD4/CD8 ratios for mice with a specific genotype are listed, expressed
as geometric mean (± s.d.). Significant loci are in bold and Tcra markers are underlined. A total of 31 F2 mice were analysed.
ratio. A second congenic mouse strain, B10.A-Tcrac/AI
(B10.A mice containing the Tcrac locus from strain SJL),
compared with B10.A mice (Figure 2c) also showed signif-
icant differences in thymic CD4/CD8 ratios. The telom-
eric crossover of the Tcraa congenic mapped between 19.5
and 25.0 cM (Figure 2a), consistent with previous restric-
tion fragment linked polymorphism (RFLP) mapping to
18.0–27.0 cM [19], and the centromeric boundary of the
Tcrac congenic mapped between 17.0 and 18.5 cM.
Together, the effect on CD4/CD8 ratios mapped between
17.0 and 25.0 cM.
The distribution of TCR Va genes in CD4 and CD8 subsets
The TCR repertoire is a complex collection in which no
single Vα is expressed in sufficiently high proportion to
dominate the T-cell skewing. Thus, it is likely that the
effects of different Tcra haplotypes on the CD4/CD8 ratio
are due to the cumulative effects of many TCR Vα ele-
ments. A tabulation of peripheral T-cell expression of the
few TCR Vα families studied to date (totaling less than
20% of the total T-cell repertoire) illustrates this point
(Table 2). While individual TCR Vα families (when
present) showed skewing toward CD4 or CD8, the overall
skewing shows a higher CD4/CD8 ratio among the
BALB/c as compared to the B6 T cells.
The effects on CD4/CD8 ratios were influenced by three
distinct Tcra haplotypes; as very few genes show this much
allelic variation (other than MHC), our results are strongly
suggestive of a primary role for this gene complex. More-
over, consideration of nearby genes confirmed that Tcra is
the most likely candidate. A defect in Np, involved in purine
metabolism, would be predicted to be a recessive trait, not
the co-dominant trait observed. The granzymes (Gzmb-g)
are involved in cytotoxic T lymphocyte function, but they
show little polymorphism and disruption of the gene did not
alter thymic CD4/CD8 ratio [20]. The Cebpe gene is
expressed in the myeloid lineage, but is undetectable in the
thymus [21]. Dad1 and bcl-w are expressed in most tissues
and are highly conserved through evolution [22,23]. Expres-
sion of bcl-w is very low in lymphoid cells, being mainly
expressed in myeloid cells [23]. It should be noted that the
present linkages were found by comparing B6 and BALB/c
strains. In another F2 cross between B6 and DBA/2 (Tcrad),
no significant associations were found at any of the chromo-
some 3, 10, 11, 14 and 17 loci tested (data not shown).
The effects of the Tcra locus may be a major influence over
thymic skewing, in addition to other mechanisms favouring
CD4 production [1–3,24]. It is possible that the overall pref-
erence for single-positive CD4+ T cells is due largely to an
intrinsic preference among the majority of Tcra-V genes for
class II MHC binding that was selected through evolution
of the TCR genes. That is, there may be no such thing as
an MHC class-neutral TCR repertoire. Indeed, the majority
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Figure 2
CD4/CD8 ratio in Tcra congenic strains. (a) Recombinant boundaries
of B10.D2-Tcraa and B10.A-Tcrac congenic mice. Markers near the
Tcra locus were used to map the boundaries of the congenic mouse
strains. The allele designations for each mouse strain are ‘a’ for
BALB/c, ‘b’ for B6/B10, and ‘c’ for SJL. D14Mit113 does not
differentiate between Tcrab and Tcrac. (b) Thymic CD4/CD8 ratios as
geometric mean (± SD) were 4.30 (± 1.09) for B10.D2-Tcraa
congenic mice and 3.37 (± 1.16) for control B10.D2 (p = 0.0002 by
student’s t-test). (c) A significant difference in thymic CD4/CD8 ratios
was also observed for B10.A-Tcrac congenic mice, 3.63 (± 1.11), and
control B10.A, 3.03 (± 1.16); p = 0.0023, student’s t-test.

Th
ym
ic
 C
D
4/
C
D
8 
ra
tio
Th
ym
ic
 C
D
4/
C
D
8 
ra
tio

2.0
3.0
4.0
5.0
B10.D2
(b) (c)
2.0
3.0
4.0
D14Mit60
(15.0 cM)
D14Mit101
(17.0 cM)
 D14Mit62
(18.5 cM)
 D14Mit142
(19.5 cM)
 D14Mit113
(25.0 cM)
D14Mit37
(27.5 cM)
B10.D2-Tcraa
B10.D2-Tcraa B10.A B10.A-Tcrac
B10.A-Tcrac
BALB/c
SJL
B10.D2
B10.A
a
b
a
c
b
b
a
b
a
c
b
b
a
c
a
c
b
b
a
c
a
c
b
b
b
(c)
a
c
b
b
b
c
a
c
b
b
(a)
Current Biology
Table 2
Cumulative effect of various Va elements on CD4/CD8 ratio. 
Strain Subset Vα2 Vα3* Vα3.2 Vα8† Vα11.1/2 Sum CD4/CD8
B6 (Tcrab) CD8 3.33 ± 0.66 3.98 ± 0.26 1.21 ± 0.20 2.24 0.65 ± 0.16 11.41
CD4 7.71 ± 0.58 6.88 ± 0.55 0.42 ± 0.11 1.95 2.72 ± 0.25 19.68 1.72
BALB/c (Tcraa) CD8 1.30 ± 0.11 2.95 ± 0.18 0 0.56 0 4.81
CD4 6.82 ± 0.60 7.22 ± 1.52 0 2.00 0 16.04 3.33
The frequency of expression of each denoted Vα is expressed as a
percentage of that particular Vα with regard to total Thy1.2+ lymph
node cells. Antibodies against Vα2 (B20.1) [6], Vα3.2 (RR3-16) [8]
and Vα11 (RR8-1) [5] were from PharMingen (San Diego). The Vα3
antiserum [13] was a kind gift from Mark Green (University of
Pennsylvania). *As the Vα3 antiserum cross-reacts with Vα3.2, data for
Vα3 are values after subtraction of Vα3.2. †Data from [9]. 
of individual Tcra-V elements examined showed skewed
selection into CD4+ cells ([5–7]; reviewed in [10]). This is
consistent with arguments that the TCR evolved with an
intrinsic preference for MHC binding in general [11,12].
Analyses of two TCR–class I MHC–peptide complexes
[25,26] suggested how the Vα might have a predominant
role in the interaction with MHC. Strikingly, residues of
Vα3 that were found to change skewing from CD4 to CD8
cell subsets [7,13] were found to be the same residues
making conserved hydrogen bonds to class I molecules
[25]. The regions on the class I α helices that are con-
tacted by CDR1α and CDR2α have a different structure
in class II molecules. Also, the conserved class I residues
contacted by Vα are different residues in class II, but they
are conserved among class II alleles. This provides a com-
pelling explanation for the skewed selection of TCR Vα
elements ([5–9,13]; reviewed in [10]).
The Tcra-linked influence over CD4/CD8 ratios in the
periphery may secondarily affect peripheral immune
responses. Indeed, studies on the genetics of autoimmu-
nity in NOD mice (Tcrac) revealed significant linkage to
loci (Idd-8 and Idd-12) on chromosome 14 near the Tcra
locus [27]. Specific Tcra-V genes may have a strong affin-
ity for the NOD class II allele, enhancing autoimmune
responses. Interestingly, other mouse strains susceptible
to experimental autoimmune encephalomyelitis (i.e. SJL,
SWR and PL/J) have the same Tcrac allele as the NOD
strain [28]. Thus, the predisposition for autoimmunity
may be helped by Tcra-linked influences over the genera-
tion of CD4+ versus CD8+ lymphocytes.
Supplementary material
Supplementary material published with this paper on the internet
includes a correlation between Tcra haplotypes and CD4/CD8 ratios
among common mouse strains (Table S1); mixed bone marrow
chimæra studies on CD4/CD8 ratios (Table S2); a complete listing of
the microsatellite data from the CB6F2 cross (Table S3); and the 
Tcra-linked effect on CD3– thymocytes (Table S4).
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S1
Mice strains used in this study 
C57BL/6J (B6) is H-2b, Thy-1.2, Tcrab; BALB/c is H-2d,
Thy-1.2, Tcraa; C.B10-H-2b (BALB.B) is H-2b, Thy-1.2,
Tcraa, BALB background; B6.PL-Thy-1a/Cy (Jackson
Laboratories, Bar Harbor, ME); B6.PL is H-2b, Thy-1.1,
Tcrab, C57BL background; SJL/J (Jackson) is H-2s,
Thy1.2, Tcrac; DBA/2 is H-2d, Thy-1.2, Tcrad; B10.D2
(Jackson) is H-2d, Thy-1.2, Tcrab, C57BL/10 background;
B10.D2-Tcraa/Bo (University of Oslo, Norway) is H-2d,
Thy-1.2, Tcraa, C57BL/10 background, derived from 11
backcrosses to B10.D2 [19]; and B10.A-H2aTlaa/SgSnJ
(Jackson) (B10.A) is H-2a, Thy1.2, Tcrab, C57BL/10 back-
ground. B10.A-Tcrac/AI (LCMI, NIAID, NIH) is H-2a,
Thy1.2, Tcrac, C57BL/10 background. This Tcra congenic
was derived by crossing B10.A/SgSnAI to SJL/J and then
backcrossing the F1 offspring 12 times to B10.A/SgSnAI,
selecting for the presence of the SJL Vα RFLP in the Tcra
locus. At N13, the mice were intercrossed to established
the strain. CB6 is (B6×BALB/c)F1, and CB6F2 is an F2
cross between CB6. All mice were used at 4–8 weeks of
age and were obtained from The Scripps Research Insti-
tute vivarium, except as noted, cared for as prescribed by
NIH and institutional guidelines.
Supplementary material
Table S2
CD4/CD8 ratio is determined by the genotype of the donor
stem cells. 
Lymph node
Chimæra CD4/CD8 (Thy-1.2+) CD4/CD8 (Thy-1.1+)
BALB.B→CB6 4.49 (± 1.06) —
BALB.B+B6.PL→CB6 4.37 (± 1.15) 2.65 (± 1.18)
B6PL→CB6 — 3.16 (± 1.12)
B6+B6.PL→CB6 3.11 (± 1.21) 3.55 (± 1.22)
B6→CB6 2.90 (± 1.04) —
(B6×BALB.B)F1→CB6 2.67 (± 1.09) —
Radiation bone marrow chimæras were made either with BALB.B (Thy-
1.2+), B6.PL (Thy-1.1+), B6 (Thy-1.2+) and (B6×BALB.B)F1 as donor
bone marrow cells or with an equal mix of BALB.B and B6.PL, B6 and
B6.PL as donor cells. The panel of bone-marrow-derived stem cells
were used to reconstitute irradiated CB6 mice. Based on their
respective Thy-1 alleles, the different population of donor cells in lymph
nodes were distinguished and analysed in FACS analysis. The
percentage of CD4+ and CD8+ T cells in the appropriate population of
Thy-1+ cells was determined and the CD4/CD8 ratio calculated. Data
shown are the CD4/CD8 ratios of the different chimæras tested as
geometric mean (± SD). Student’s t-test shows that BALB.B cells
have a significantly higher CD4/CD8 ratio than B6.PL cells whether
alone in the chimæra (p = 0.0374) or in mixtures with B6.PL cells
(p = 0.0035). Controls of B6 bone marrow cells, alone or in a mixture
with B6.PL cells, do not show a significant difference in CD4/CD8
ratio (p = 0.4793 and p = 0.3818, respectively).
Table S1
Correlation between Tcra haplotypes and CD4/CD8 ratios. 
Strain Lymph node CD4/CD8* Tcra†
B6 1.12 (± 0.50) b
B10 0.98 (± 0.55) b
B10.BR 0.98 (± 0.55) b
B10.A 1.04 (± 0.01) b
B10.D2 1.28 (± 0.23) b
C57/L 1.15 (± 0.01) b
CBA/J 2.09 (± 0.15) a
CBA/Ca 2.36 (± 0.55) a
A/J 2.00 (± 0.03) a
DBA/2 2.83 (± 0.19) d
SJL 2.03 (± 0.11) c
C3H/HeJ 2.09 (± 0.08) a
BALB.B 2.38 (± 0.22) a
BALB/c 2.32 (± 0.12) a
(B6×DBA/2)F1 1.38 (± 0.03) b/d
(B6×CBA/J)F1 2.02 (± 0.37) b/a
*Lymph node CD4/CD8 ratios are from [15]. †The Tcra haplotypes of
the various mouse strains are taken from [28].
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Table S3
(a) The CD4/CD8 ratio of CB6F2 mice is linked to the genotype on chromosome 14. 
Microsatellite Chromosome cM* CB6F2 ‘a’† CB6F2 ‘a/b’† CB6F2 ‘b’† p value‡
D1Mit425 1 81.6 3.9 (± 1.5) 3.3 (± 1.6) 3.5 (± 1.6) 0.6549
D1Mit113 1 92.3 3.5 (± 1.4) 3.4 (± 1.7) 3.6 (± 1.4) 0.9601
D2Mit66 2 47.0 3.6 (± 1.6) 3.0 (± 1.6) 4.1 (± 1.5) 0.2676
D2Mit423 2 68.9 4.3 (± 1.4) 2.8 (± 1.5) 3.6 (± 1.6) 0.0722
D3Mit164 3 2.4 3.4 (± 1.7) 3.6 (± 1.6) 3.3 (± 1.5) 0.9168
D3Mit65 3 23.3 3.7 (± 1.4) 3.7 (± 1.6) 3.1 (± 1.6) 0.3945
D3Mit106 3 55.0 3.3 (± 1.8) 3.3 (± 1.5) 4.2 (± 1.6) 0.4938
D3Mit19 3 87.6 3.3 (± 1.7) 3.4 (± 1.5) 4.3 (± 1.4) 0.5500
D4Mit286 4 14.5 4.4 (± 1.2) 3.4 (± 1.4) 3.2 (± 1.8) 0.3840
D4Mit178 4 35.5 4.8 (± 1.1) 3.4 (± 1.4) 3.0 (± 1.9) 0.0759
D5Mit233 5 29.0 2.8 (± 1.8) 3.8 (± 1.5) 3.7 (± 1.4) 0.6383
D5Mit168 5 80.0 4.5 (± 1.3) 3.1 (± 1.7) 3.6 (± 1.4) 0.3437
D6Mit83 6 3.0 3.6 (± 1.7) 3.5 (± 1.5) 3.3 (± 1.3) 0.8080
D6Mit74 6 20.5 4.2 (± 1.5) 3.3 (± 1.6) 3.3 (± 1.3) 0.2590
D6Mit287 6 49.0 3.9 (± 1.6) 3.3 (± 1.5) 3.5 (± 1.6) 0.6037
D6Mit201 6 75.0 3.0 (± 1.7) 3.9 (± 1.4) 3.2 (± 1.6) 0.5954
D7Mit178 7 1.5 4.4 (± 1.6) 3.5 (± 1.6) 3.0 (± 1.4) 0.2760
D7Mit306 7 2.0 4.2 (± 1.5) 3.4 (± 1.6) 3.1 (± 1.4) 0.4001
D7Mit117 7 11.0 3.6 (± 1.9) 3.6 (± 1.4) 4.0 (± 1.4) 0.7423
D8Mit261 8 33.0 3.2 (± 1.4) 4.3 (± 1.4) 2.8 (± 1.7) 0.1019
D8Mit121 8 67.0 3.3 (± 1.5) 3.8 (± 1.1) 3.1 (± 1.3) 0.7633
D9Mit254 9 25.0 3.4 (± 1.7) 3.5 (± 1.5) 3.5 (± 1.6) 0.9552
D9Mit182 9 55.0 3.4 (± 1.5) 3.2 (± 1.6) 4.1 (± 1.5) 0.4158
D10Mit189 10 5.0 3.1 (± 1.5) 4.1 (± 1.7) 3.3 (± 1.4) 0.1013
D10Mit264 10 48.0 4.4 (± 1.4) 3.3 (± 1.6) 2.9 (± 1.7) 0.2388
D10Mit230 10 50.0 4.4 (± 1.4) 3.1 (± 1.6) 3.3 (± 1.5) 0.2624
D10Mit95 10 51.0 4.5 (± 1.4) 3.4 (± 1.5) 2.7 (± 1.7) 0.0964
D10Mit70 10 59.0 4.1 (± 1.7) 3.2 (± 1.5) 3.5 (± 1.5) 0.2195
D11Mit226 11 1.0 3.8 (± 1.4) 3.3 (± 1.7) 3.1 (± 1.4) 0.6336
D11Mit230 11 16.0 3.7 (± 1.5) 4.0 (± 1.4) 3.2 (± 1.7) 0.7508
D11Mit41 11 49.0 3.5 (± 1.7) 3.7 (± 1.4) 3.4 (± 1.6) 0.9659
D12Mit114 12 29.0 3.5 (± 1.7) 3.7 (± 1.6) 3.3 (± 1.4) 0.6406
D13Mit179 13 30.0 3.2 (± 1.7) 3.9 (± 1.4) 3.4 (± 1.7) 0.4633
D13Mit130 13 61.0 3.3 (± 1.7) 3.4 (± 1.5) 4.1 (± 1.3) 0.6462
D14Mit60 14 15.0 4.9 (± 1.4) 3.5 (± 1.3) 2.2 (± 1.6) 0.0019
D14Mit101 14 17.0 4.9 (± 1.4) 3.6 (± 1.3) 1.9 (± 1.5) 0.0010
D14Mit121 14 17.0 4.9 (± 1.4) 3.5 (± 1.3) 2.2 (± 1.6) 0.0019
D14Mit62 14 18.5 4.9 (± 1.4) 3.5 (± 1.3) 1.9 (± 1.5) 0.0007
D14Mit142 14 19.5 4.9 (± 1.4) 3.5 (± 1.3) 1.9 (± 1.5) 0.0007
D14Mit113 14 25.0 4.8 (± 1.4) 3.8 (± 1.3) 1.9 (± 1.5) 0.0021
D14Mit37 14 27.5 4.8 (± 1.4) 3.5 (± 1.4) 1.9 (± 1.6) 0.0039
D16Mit84 16 32.3 3.6 (± 1.4) 3.0 (± 1.6) 5.1 (± 1.3) 0.0415
D17Mit133 17 10.4 2.8 (± 1.5) 3.1 (± 1.6) 4.8 (± 1.3) 0.0226
MM23 17 19.1 2.4 (± 1.6) 4.0 (± 1.5) 4.0 (± 1.2) 0.0279
D17Mit178 17 24.5 2.3 (± 1.5) 4.2 (± 1.6) 4.0 (± 1.2) 0.0074
D17Mit187 17 47.4 3.0 (± 2.0) 3.5 (± 1.5) 4.0 (± 1.3) 0.6191
D18Mit188 18 47.0 2.4 (± 2.0) 3.8 (± 1.5) 3.9 (± 1.4) 0.4862
D19Mit19 19 26.0 3.3 (± 1.4) 4.1 (± 1.4) 3.0 (± 1.8) 0.4079
D19Mit34 19 53.0 3.3 (± 1.5) 3.7 (± 1.6) 3.4 (± 1.6) 0.8112
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Table S3
(b) The peripheral CD4/CD8 ratio of CB6F2 mice is linked to the genotype on chromosome 14.
Microsatellite Chromosome cM* CB6F2 ‘a’† CB6F2 ‘b’† p value‡
D3Mit164 3 2.4 2.1 (± 1.3) 1.7 (± 1.2) 0.1199
D3Mit65 3 23.3 2.1 (± 1.3) 1.7 (± 1.1) 0.0903
D3Mit106 3 55.0 2.1 (± 1.3) 1.8 (± 1.2) 0.1412
D3Mit19 3 87.6 2.0 (± 1.2) 1.8 (± 1.2) 0.1751
D10Mit189 10 5.0 1.8 (± 1.3) 1.9 (± 1.2) 0.1248
D10Mit264 10 48.0 1.9 (± 1.2) 1.6 (± 1.2) 0.0539
D11Mit226 11 1.0 1.9 (± 1.2) 1.6 (± 1.4) 0.0815
D11Mit230 11 16.0 1.9 (± 1.2) 1.8 (± 1.3) 0.4385
D11Mit41 11 49.0 1.8 (± 1.2) 1.9 (± 1.2) 0.3962
D14Mit60 14 15.0 2.0 (± 1.2) 1.8 (± 1.2) 0.1412
D14Mit101 14 17.0 2.0 (± 1.2) 1.7 (± 1.2) 0.0637
D14Mit121 14 17.0 2.0 (± 1.2) 1.8 (± 1.2) 0.1412
D14Mit62 14 18.5 2.1 (± 1.2) 1.7 (± 1.2) 0.0415
D14Mit142 14 19.5 2.1 (± 1.2) 1.7 (± 1.2) 0.0415
D14Mit113 14 25.0 2.1 (± 1.2) 1.7 (± 1.2) 0.0466
D14Mit37 14 27.5 2.1 (± 1.2) 1.8 (± 1.1) 0.1071
D16Mit84 16 32.3 1.8 (± 1.2) 2.2 (± 1.2) 0.0709
D17Mit133 17 10.4 1.8 (± 1.2) 2.1 (± 1.2) 0.0273
MM23 17 19.1 1.8 (± 1.2) 2.0 (± 1.3) 0.1383
D17Mit178 17 24.5 1.7 (± 1.2) 1.9 (± 1.3) 0.1048
D17Mit187 17 47.4 1.9 (± 1.2) 1.9 (± 1.2) 0.4775
(a) Thymic and (b) peripheral CD4/CD8 ratios of CB6F2 mice retain
linkage to chromosome 14. The panel of microsatellite markers is listed
in column one (only selected markers are shown). *Chromosomal
location (cM). †CB6F2 mice with the BALB/c allele are denoted as ‘a’,
and with the B6 allele as ‘b’. Under the appropriate ‘a’ and ‘b’ columns
are peripheral lymph node CD4/CD8 ratios, expressed as geometric
mean (± SD), of mice typed similarly with a particular microsatellite
marker. ‡The p values were calculated from geometric means using the
Kruskall–Wallis test (a) and the Mann–Whitney test (b). Significant loci
are in bold and the Tcra and H-2 markers are underlined. A total of 31
F2 mice were analysed.
Table S4
Tcra-linked influence on CD3– thymocytes.
Strain CD3–CD4–CD8+ CD3–CD4–CD8+
as % of CD4–CD8+ as % of total thymocytes
B6 (n = 14) 18.60 ± 3.26 0.44 ± 0.12
BALB/c (n = 10) 16.14 ± 3.80 0.28 ± 0.007
p value* 0.1029 0.0007
The CD3– thymocyte population was analysed as a percentage of
CD8+ single positives as well as a percentage of total thymocytes.
*Significance level was determined by student’s t-test.
